Event 
Partner 
Milestone 
2018-05-01
Apr 25 ACT Genomics Scientific Talk at Siriraj Hospital
ACT Genomics is honoured to be invited to give a scientific talk at Siriraj Hospital in Thailand. Dr. Poon shared the challenges & promises of comprehensive genomic profiling and biomarkers in cancer immunotherapy.
Place:
Thailand
2018-05-01
Apr 19 ACT Genomics Scientific Talk at Cipto Mangunkusumo General Hospital
ACT Genomics is honoured to be invited to give a scientific talk at Cipto Mangunkusumo General Hospital, Jakarta. Dr. Liisa shared on the topic: Can Next Generation Sequencing fulfill its promises in cancer management in the era of precision medicine?
Place:
Jakarta
2018-05-01
Apr 15 ACT Genomics Hong Kong shared hereditary cancer information in Macau
ACT Genomics Hong Kong is honoured to be invited to give a scientific talk at Associa??o de Profissionais de Medicina Chinesa de Macau. Dr. Timothy Yip, ACT Genomics representative and Dr. Joseph Siu-Kie Au, Specialist in Clinical Oncology, Hong Kong Adve
Place:
Macau
2018-05-01
Apr 06 ACT Genomics visited University of Macau for future cooperation
ACT Genomics visited University of Macau and learned about their current findings in zebrafish gonad development and single-cell dynamics lectured by Prof. Chung Bon-Chu and Prof. Chen Sheng-Hong at University of Macau.
Place:
Macau
2018-03-31
Apr 04&06 ACT Genomics is invited to share promises and challenges of NGS in Singapore
Dr. Maarja-Liisa Nairismagi will be sharing on the topic, Can Next Generation Sequencing Fulfill its Promises in Cancer Management in the Era of Precision Medicine and promises and challenges of Next Generation Sequencing in cancer management.
Place:
Singapore
2018-03-31
Mar 23 An exemplary high-tech biomedical enterprise in Southeast Asia
ACT Genomics successfully positions itself as an exemplary high-tech enterprise for Taiwan’s biomedical companies in their south bound strategy to clinch the emerging market
Place:
Singapore
2018-03-31
Mar 20 Finding a way to avoid genetic discrimination
Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics joined oncologists to explore detection of germline mutations with NGS, share cases of early cancer treatment, and discuss how to assist patients with hereditary genetic mutations to avoid genetic
Place:
Hong Kong
2018-03-31
Mar 19 The rising star in Asia’s genomic profiling platform
Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics introduced how personal genomic information can be transformed into guidance for cancer treatment selection through their know-how, which attracted investors’ attention.
Place:
Japan
2018-03-31
Mar 16 ACT Genomics shared NGS experiences in cancer management
. Dr. Maarja-Liisa Nairismagi shared on promises and challenges of Next Generation Sequencing in cancer management in Singapore
Place:
Singapore
2018-03-31
Mar 09 NGS market insight for Economist Intelligence Unit
Dr. Allen Lai, Senior Vice President, has been interviewed by EIU on 9th March to provide his critical in-field observation of the trend and the adoption challenges of NGS in the years to come in Southeast Asia and beyond.
Place:
Singapore
